FEI Transmission Electron Microscope with Tomography Capability
FEI Transmission Electron Microscope with Tomography Capability
批准号:
7596130
负责人:
PAUL W. SPEARMAN
金额:
$50.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2011-04-30
关键词:
AmyloidAmyloid ProteinsAreaArtsBiocompatible MaterialsBiosensorCore FacilityDevelopmentDrug Delivery SystemsEbola virusElectron MicroscopeElectron MicroscopyEnsureFoundationsFundingGenerationsHIV vaccineHousingImageLaboratoriesMaintenanceMembrane ProteinsMicroscopeMinorityNanotechnologyProductivityProteinsPublic HealthRequest for ApplicationsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResolutionRetroviridaeServicesTechniquesTimeUnited States National Institutes of HealthUniversitiesVirus-like particlebaseinstrumentinstrumentationnanoparticlenovelnovel virusprotein foldingpublic health relevancesuccesstomographytransmission processvaccine developmentvirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There is an urgent need on the Emory University campus for a state-of-the-art TEM to serve a multi-user group of investigators. The University has recently re-organized its core laboratories housing electron microscopes into a single shared facility, the Integrated Electron Microscopy Core. An FEI Tecnai G2 TEM is requested as a major foundation of this new core facility. The major objective of this application is to enhance EM instrumentation on the Emory campus in order to facilitate a broad array of NIH- funded research projects. This instrument will be used extensively by a group of six investigators whose projects require advanced TEM techniques. The instrument will be the only one on campus with a high resolution CCD, remote image viewing capability, and the capacity for tomography. The projects of the major users include studies of basic retrovirus assembly (Spearman and Hunter), development of novel virus-like particles with altered membrane proteins as vaccines for HIV, and Ebola virus (Compans), examination of the mechanisms of amyloid aggregate formation (Lynn), development and analysis of novel nanoparticles as biosensors and drug delivery vehicles (Nie), and synthesis of novel protein-based biomaterials (Conticello). Each major user will utilize the TEM capabilities of the FEI microscope, and will explore new applications that require tomography. A large number of core instrumentation users across campus will have access to the FEI instrument under the guidance of the core technical director for the minority of usage time not taken by the major users. The impact of this instrument on research productivity is likely to be quite large, and a strong infrastructure is already in place to ensure maintenance and technical support for the instrument. This instrument is essential to an ongoing upgrade to the EM services available at Emory University, and will support a wide base of investigators on campus. Public Health Relevance: A number of projects on the Emory University campus rely on electron microscopy for their success. This application requests a new instrument that will greatly facilitate research in the areas of virology, vaccine development, nanotechnology, amyloid protein folding, and generation of new biomaterials. The new microscope will benefit these projects and a wide range of other projects on campus that will yield benefits to public health.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.7150/thno.62724
发表时间:
2021
期刊:
Theranostics
影响因子:
12.4
作者:
[Garlapati C, Joshi S, Turaga RC, Mishra M, Reid MD, Kapoor S, Artinian L, Rehder V, Aneja R]
通讯作者:
Aneja R
DOI:
10.1091/mbc.e16-10-0707
发表时间:
2017-06-15
期刊:
Molecular biology of the cell
影响因子:
3.3
作者:
[Matsunaga Y, Hwang H, Franke B, Williams R, Penley M, Qadota H, Yi H, Morran LT, Lu H, Mayans O, Benian GM]
通讯作者:
Benian GM
DOI:
10.1111/bpa.12425
发表时间:
2017-07
期刊:
Brain pathology (Zurich, Switzerland)
影响因子:
--
作者:
[Jiang MQ, Zhao YY, Cao W, Wei ZZ, Gu X, Wei L, Yu SP]
通讯作者:
Yu SP
DOI:
10.1038/srep40360
发表时间:
2017-01-06
期刊:
Scientific reports
影响因子:
4.6
作者:
[Kumar A, Kim JH, Ranjan P, Metcalfe MG, Cao W, Mishina M, Gangappa S, Guo Z, Boyden ES, Zaki S, York I, García-Sastre A, Shaw M, Sambhara S]
通讯作者:
Sambhara S
DOI:
10.1016/j.nbd.2016.09.013
发表时间:
2016-12
期刊:
NEUROBIOLOGY OF DISEASE
影响因子:
6.1
作者:
[Lee, Jin Hwan, Wei, Zheng Z., Cao, Wenyuan, Won, Soonmi, Gu, Xiaohuan, Winter, Megan, Dix, Thomas A., Wei, Ling, Yu, Shan Ping]
通讯作者:
Yu, Shan Ping
共 7 条
Modeling HIV and methamphetamine-induced neuroinflammation in cerebral organoids
-
批准号:10528845
-
项目类别:
-
资助金额:$59.88万
-
财政年份:2022
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes
-
批准号:10399644
-
项目类别:
-
资助金额:$49.53万
-
财政年份:2020
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes
-
批准号:10611438
-
项目类别:
-
资助金额:$49.53万
-
财政年份:2020
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes
-
批准号:10206089
-
项目类别:
-
资助金额:$49.53万
-
财政年份:2020
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes
-
批准号:10055497
-
项目类别:
-
资助金额:$49.53万
-
财政年份:2020
-
负责人:PAUL W. SPEARMAN
-
依托单位:
HIV-Specific B Cell Repertoire in Humans Following Cross-Clade Immunization
-
批准号:8410925
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2012
-
负责人:PAUL W. SPEARMAN
-
依托单位:
HIV-Specific B Cell Repertoire in Humans Following Cross-Clade Immunization
-
批准号:8500181
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2012
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Defining Neutralization Breadth in HIV+ Human Serum
-
批准号:7936231
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Defining Neutralization Breadth in HIV+ Human Serum
-
批准号:7761618
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Pseudovirion Formation by Live Vector HIV Vaccines
-
批准号:7244076
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2006
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Pseudovirion Formation by Live Vector HIV Vaccines
-
批准号:7064371
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2006
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Novel Assays for Inhibitors of HIV Assembly
-
批准号:7219144
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
A PROBE STUDY OF THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF A THREE-DOSE
-
批准号:7375585
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Novel Assays for Inhibitors of HIV Assembly
-
批准号:7074573
-
项目类别:
-
资助金额:$26.15万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
NORMAL VOLUNTEER BLOOD DONATION
-
批准号:7375578
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
A PROBE STUDY OF THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF HUMAN IMMUNO
-
批准号:7375574
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Novel Assays for Inhibitors of HIV Assembly
-
批准号:7002581
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
A PHASE I SAFETY AND IMMUNOGENICITY TRIAL OF AN ALPHAVIRUS REPLICON HIV SUBTY
-
批准号:7375597
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
Novel Assays for Inhibitors of HIV Assembly
-
批准号:7246607
-
项目类别:
-
资助金额:$25.39万
-
财政年份:2005
-
负责人:PAUL W. SPEARMAN
-
依托单位:
A PHASE I DOSE-RANGING STUDY OF THE SAFETY, TOLERABILITY, AND IMMUNOGENCITY
-
批准号:7207258
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2004
-
负责人:PAUL W. SPEARMAN
-
依托单位:
海外基金